David MILLER,Angus MACLEOD,Susana DEL RIO GANCEDO,Samuel Alexander STRATFORD
申请号：
US16850978
公开号：
US20200237723A1
申请日:
2020.04.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a sodium salt of N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H-pyrazole-3-sulfonamide and to hydrates, solvates and polymorphic forms thereof. The present invention further relates to pharmaceutical compositions comprising this compound and the use of this compound in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.
